Jentadueto XR (linagliptin 2.5 MG / metformin HCl 1000 MG) 24HR Extended Release Oral Tablet
- RxCUI
- 1796091
- RxNorm name
- Jentadueto XR (linagliptin 2.5 MG / metformin HCl 1000 MG) 24HR Extended Release Oral Tablet
- Display name
- Jentadueto XR (linagliptin 2.5 MG / metformin HCl 1000 MG) 24HR Extended Release Oral Tablet
- Full name
- Jentadueto XR (linagliptin 2.5 MG / metformin HCl 1000 MG) 24HR Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jentadueto XR | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | 2024-05-24 | Boxed warning, Warnings, Adverse reactions | 1796091 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | Jentadueto XR (linagliptin 2.5 MG / metformin HCl 1000 MG) 24HR Extended Release Oral Tablet | SY | 9 | These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2012 | 20240524 |
| 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | 24 HR linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Jentadueto] | SBD | 9 | These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2012 | 20240524 |
| 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | Jentadueto XR 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | PSN | 9 | These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2012 | 20240524 |